Zhuge Y, Zhang J, Qian F, Wen Z, Niu C, Xu K, et al. Role of smooth muscle cells in Cardiovascular Disease. Int J Biol Sci. 2020;16:2741–51.

Article  PubMed  PubMed Central  Google Scholar 

Khachigian LM, Varcoe RL, Suoranta T, Laham-Karam N, Yla-Herttuala S. Gene therapeutic strategies for peripheral artery disease and new opportunities provided by adeno-associated virus vectors. Arterioscler Thromb Vasc Biol. 2023;43:836–51.

Article  CAS  PubMed  Google Scholar 

Raghavan A, Pirruccello JP, Ellinor PT, Lindsay ME. Using Genomics to Identify Novel Therapeutic Targets for Aortic Disease. Arterioscler Thromb Vasc Biol. 2024;44:334–51.

Article  CAS  PubMed  Google Scholar 

Yang G, Khan A, Liang W, Xiong Z, Stegbauer J. Aortic aneurysm: pathophysiology and therapeutic options. MedComm (2020). 2024;5:e703.

Article  CAS  PubMed  Google Scholar 

Schroder LC, Huttermann L, Kliesow Remes A, Voran JC, Hille S, Sommer W, et al. AAV library screening identifies novel vector for efficient transduction of human aorta. Gene Ther. 2024. https://doi.org/10.1038/s41434-024-00511-8. ahead of print

Article  PubMed  Google Scholar 

Destro F, Wu W, Srinivasan P, Joseph J, Bal V, Neufeld C, et al. The state of technological advancement to address challenges in the manufacture of rAAV gene therapies. Biotechnol Adv. 2024;76:108433.

Article  CAS  PubMed  Google Scholar 

Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther. 2024;9:78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mingozzi F, High KA. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood. 2013;122:23–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gruchala M, Bhardwaj S, Pajusola K, Roy H, Rissanen TT, Kokina I, et al. Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors. J Gene Med. 2004;6:545–54.

Article  CAS  PubMed  Google Scholar 

Lompre AM, Hadri L, Merlet E, Keuylian Z, Mougenot N, Karakikes I, et al. Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy. Gene Ther. 2013;20:901–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Korbelin J, Dogbevia G, Michelfelder S, Ridder DA, Hunger A, Wenzel J, et al. A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol Med. 2016;8:609–25.

Article  PubMed  PubMed Central  Google Scholar 

Korbelin J, Sieber T, Michelfelder S, Lunding L, Spies E, Hunger A, et al. Pulmonary targeting of adeno-associated viral vectors by next-generation sequencing-guided screening of random capsid displayed peptide libraries. Mol Ther. 2016;24:1050–61.

Article  PubMed  PubMed Central  Google Scholar 

Varadi K, Michelfelder S, Korff T, Hecker M, Trepel M, Katus HA, et al. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors. Gene Ther. 2012;19:800–9.

Article  CAS  PubMed  Google Scholar 

Ramirez SH, Hale JF, McCarthy S, Cardenas CL, Dona K, Hanlon KS, et al. An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature. Hum Gene Ther. 2023;34:682–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Remes A, Basha DI, Puehler T, Borowski C, Hille S, Kummer L, et al. Alginate hydrogel polymers enable efficient delivery of a vascular-targeted AAV vector into aortic tissue. Mol Ther Methods Clin Dev. 2021;21:83–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hooshdaran B, Pressly BB, Alferiev IS, Smith JD, Zoltick PW, Tschabrunn CM, et al. Stent-based delivery of AAV2 vectors encoding oxidation-resistant apoA1. Sci Rep. 2022;12:5464.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murzi M, Farneti PA, Rizza A, Di Sibio S, Palmieri C, Solinas M. Hybrid approach in acute and chronic aortic disease. Medicina. 2021;58:49.

Article  PubMed  PubMed Central  Google Scholar 

Geisler A, Jungmann A, Kurreck J, Poller W, Katus HA, Vetter R, et al. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Ther. 2011;18:199–209.

Article  CAS  PubMed  Google Scholar 

Qiao C, Yuan Z, Li J, He B, Zheng H, Mayer C, et al. Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver. Gene Ther. 2011;18:403–10.

Article  CAS  PubMed  Google Scholar 

Zinn E, Unzu C, Schmit PF, Turunen HT, Zabaleta N, Sanmiguel J, et al. Ancestral library identifies conserved reprogrammable liver motif on AAV capsid. Cell Rep Med. 2022;3:100803.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cabanes-Creus M, Navarro RG, Liao SHY, Baltazar G, Drouyer M, Zhu E, et al. Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsids. Mol Ther Methods Clin Dev. 2021;21:607–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoffman JA, Denton N, Sims JJ, Meggersee R, Zhang Z, Olagbegi K, et al. Modulation of AAV9 Galactose binding yields novel gene therapy vectors and predicts cross-species differences in glycan avidity. Hum Gene Ther. 2024;35:734–53.

Article  CAS  PubMed  Google Scholar